Announcement GE Healthcare’s CEO Peter Arduini is molding a new chapter for the overall $20 billion in business gained over the year. GE Healthcare Technologies was first introduced as a standalone public company on the Nasdaq exchange. From then onwards, the stock has experienced a growth of...
Announcement Coforge Limited, a popular entity known as NIIT Technologies Limited, announced its acquisition of Encora. Encora is a California-based technology services company specialising in elevating advancement and innovation for businesses via its promising expertise in Cloud, Data and AI tech...
Announcement Morgan Stanley has cut its firm’s price to $4 from $5 for GoodRx (GDRX). GoodRx Holdings Inc. is one of the most affordable penny stocks to invest in. Morgan has maintained a consistent rate for shares of other companies. Learning the next year's overview for the Healthcare Servi...
Announcement Nona Biosciences, a leading biotechnology company thoroughly modernising the discovery pathway via innovative technology platforms have now extended its unified development and exploratory framework to contribute largely to Investigator-Initiated Trials (IITs) and early clinical develo...
Announcement Italfarmaco S.p.A and JCR Pharmaceuticals Co., Ltd. excitedly announced their exclusive licensing agreement for the marketing and development of givinostat in Japan. Alongside, both companies are in collaboration for rare disease area as well. Terms of the strategic deal According to...
Announcement Mabwell, a leading innovation enthusiast biopharmaceutical company with a fully unified industry chain, has declared that it has received clearance from the U.S. Food and Drug Administration (FDA) for its own established anti-ST2 monoclonal antibody to begin with a Phase 2a clinical st...
Announcement The China-based Innovent Biologics, Inc., a leading biopharmaceutical company that focuses on establishing, manufacturing, and marketing quality-standard medicines for curing autoimmune, cardiovascular, oncology, ophthalmology, metabolic, and other critical conditions, has announced ap...
Milestone CancerVax, Inc., a leading developer of a groundbreaking Universal Cancer Treatment Platform that treats cancer through the body’s immune system, revealed its year end overview, spotlighting the meaningful advancements the success achieved throughout 2025. This is like a celebration...
Announcement Phio Pharmaceuticals Corp., a well-known clinical-level siRNA biopharmaceutical company discovering therapeutics with its exclusive INTASYL® gene mutation technology to treat cancer. The company has announced that it has taken a crucial step in its drug development program for PH-7...
Announcement IRLAB Therapeutics AB, a leading company aimed on developing and exploring new treatments for Parkinson’s disease, announced that it has received a green signal for its Phase IB study of IRL757 to evaluate tolerability, signal and safety findings in Parkinson’s patients who...
